Evaluation of Fluoroquinolones for the Prevention of BK Viremia after Renal Transplantation | Zendy

Steven Gabardi | Zendy; Sushrut S. Waikar | Zendy; Spencer T. Martin | Zendy; Keri Roberts | Zendy; Jie Chen | Zendy; Lea Borgi | Zendy; Hussein Sheashaa | Zendy; Christine Dyer | Zendy; Sayeed K. Malek | Zendy; Stefan G. Tullius | Zendy; Nidyanandh Vadivel | Zendy; Mónica Grafals | Zendy; Reza Abdi | Zendy; Nader Najafian | Zendy; Edgar L. Milford | Zendy; Anil Chandraker | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Evaluation of Fluoroquinolones for the Prevention of BK Viremia after Renal Transplantation

Author(s) -

Steven Gabardi,

Sushrut S. Waikar,

Spencer T. Martin,

Keri Roberts,

Jie Chen,

Lea Borgi,

Hussein Sheashaa,

Christine Dyer,

Sayeed K. Malek,

Stefan G. Tullius,

Nidyanandh Vadivel,

Mónica Grafals,

Reza Abdi,

Nader Najafian,

Edgar L. Milford,

Anil Chandraker

Publication year - 2010

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.08261109

Subject(s) - medicine , viremia , transplantation , ciprofloxacin , levofloxacin , kidney transplantation , gastroenterology , antibiotics , immunology , human immunodeficiency virus (hiv) , microbiology and biotechnology , biology

Nearly 30% of renal transplant recipients develops BK viremia, a prerequisite for BK nephropathy. Case reports have evaluated treatment options for BK virus, but no controlled studies have assessed prophylactic therapies. Fluoroquinolone antibiotics were studied for prevention of BK viremia after renal transplantation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research